medical and psychotherapeutic treatments( CanadianT askF orce on the PeriodicH ealthE xamination1 979; Chamblessa nd Hollon1 998; Clark& Oxman2003;C ook etal.1 995; Guyatt etal.1 995; Nathan&Gorman 2002; National Instituteo fC linicalE xcellence2002). Despites omed ifferences, all available proposalsr egard RCTs (efficacystudies)a sthe "gold standard" for demonstratingthatatreatmentis efficacious. Fore xample, according tothe APA's criteria fora nE ST,a tleastt woR CTs( or controlleds ingle-case experimentso re quivalentt ime-samples designs)f rom independentresearch groups are required in which atherapygroupi ss ignificantlysuperior toanotreatmentgroup, placebo group, an alternativetreatmentor equivalentt oa n alreadyestablished therapy(Chambless&Hollon1 998; Chambless& Ollendick 2001; Task Forceo nP romotiona nd Disseminationo fP sychological Procedures1 995).F urthermore,atreatmentmanual mustbe useda nd a specific mental disorder mustbe studied. For the designationo fb eing efficaciousa nd specific,atreatmentmusthaveb een showntob es uperior to pill or psychologicalp lacebos or toa na lternativeb ona fide treatmentin at leasttwoindependentRCTs.
Randomised Controlled Studies andLevels of Evidence
RCTs are conducted under controlled experimental conditions;thustheyallow experimenterstoc ontrolf or variables thatmaysystematicallyinfluencethe outcome independentof the treatment.T he defining feature of an RCT is the randoma ssignmentof subjectstod ifferentconditions of treatment (Shadish, Cook,&Campbell 2002) . Randomisationi sr egarded as indispensable in order toe nsure thatdifferences between subjectsa re equallydistributed. Theg oal of randomisationi stoa ttributethe observed effectse xclusivelyt othe applied therapy.T hus, randomisationisusedtoe nsure the internal validity of as tudy, i.e. the validity of inferencea bout whether the observed covariationb etween treatmentand outcome reflectsacausalr elationshipf romtreatmentt o outcome (Shadishe tal.2002) . External validity referstothe questioni fthe observed relationshipb etween treatmentand outcome specified in the hypothesis under studyholdsf or differentpatients, therapists, settinga nd measures. Withine fficacyresearchthe moststringentt estis achieved by comparison withr ival treatments, thusc ontrollingf or specific and non-specific therapeutic factors (Chambless&Hollon1 998, p. 8; Gabbard, G underson & Fonagy2 002 ). Furthermore,s uch comparisonsp rovidee xplicitinformation regarding the relativeb enefitso fc ompetingtreatments. Treatmentsthatare found tobesuperior torival treatmentsare more highlyvalued. Gabbarde tal. discuss differentt ypes of RCTsthatprovide differentlevels of evidence (Gabbard, Gunderson, &F onagy2 002) . Thea uthors regardR CTsi nwhicha treatmentis compared toap sychological placebo as the second mostrigorous variantw ithinR CTs. However, in ourviewcomparisonswithtreatmentsa s usual (TAU)c an provide more stringentt eststhan placebo controlled studies, because theycontrolf or bothc ommonf actors( e.g. attention) and treatment effectso fT AU.H owever,afrequentproblem in TAU-controlled studies is that TAUi sp oorlydefined and differs from one studyt oa nother. In one study,f or example, TAUm aybe routine outpatientpsychotherapyin clinical practice, whereas in another studyitmaybe ap ure psychopharmacological treatment, and in athird studyitmayinclude counselling or other formso fh ealthc are.
Thef ourthm ostrigorousf orm of RCTsuseswaitingl istcontrols.H owever, in thistype of study,itis notclear if the observed effectin the treatmentgroupis tob ea ttributed tos pecific or non-specifictherapeutic factors ( Gabbard etal. 2002) . AccordingtoG abbard etal.( 2002) , the next level of evidencei s provided byprospectivep re-poststudies,f ollowed bycase series and finally bycase reports.
Critique of theRCT Approach
TheE BM andE ST approaches, withtheire mphasis on RCTs, followt he methodologyof pharmacologicalr esearch. Ithas been criticallydiscussed whether this methodologyis adequatef or psychotherapyresearch ( Beutler 1998; Fonagy1999; Leichsenring2004; Persons &S ilberschatz 1998; Roth& Parry1997; R othwell2005; Seligman 1995; W esten,N ovotny&T hompsonBrenner 2004) . Them aina rgumentsc an be summarized as follows: (1)T he defining featureso fR CTs such as randomisation, use of treatmentmanuals, focuso ns pecificm ental disordersa nd frequentexclusion of patientswitha poor prognosis (e.g. multimorbid patients) raisethe questiona stowhetherthe resultso fR CTsa re sufficientlyrepresentativeo fclinicalp ractice. (2)Thus, if a method of psychotherapyhas beens howntoworkunderthe controlled conditions of an RCT, this does notnecessarilyimplyt hatitequallyw orks under the conditions of clinical practice ( Leichsenring, 2004) .
(3)T he EST approach putsthe emphasis on disorders ando ns ymptoms ( Blatt 1995) .A s Henry(1998,p .129) put it:" EVTs [EmpiricallyValidated Treatments] placethe emphasis on the disorder ...a nd noton the individual... who seekso ur services." (4)A tpresent,treatmentmanuals do notexistform ultimorbid patientsa stheyu suallyoccuri nc linical practice. Thea vailable treatment manuals refertothe treatmentof isolated mental disorders. Itis widely unknownh owt he treatmentof one specific mental disorder (e.g. depressive disorder) mustbe modified according toc oexistingd isorders (e.g.s ocial phobiao rn arcissistic personality disorder).( 5) Them ethodologyof RCT with itsuse of treatmentmanualsa nd randomised control conditions is hardly applicable tol ong-term psychotherapylastings everal years ( Seligman 1995; Wallerstein1 999) .( 6)T he APA criterion of placebo control groups canb e regarded as questionable (Leichsenring2004). Thec onceptof placebo controls (nonspecifico rc ommonf actor controls)i np sychotherapyresearchi s so conceptuallyflawed thatLambertand Bergin (1994,p .1 52)p leaded, over 10y ears ago, tog iveupp lacebo controlsi np sychotherapyresearch.P lacebo effectsinp sychotherapyare, in the end, psychotherapeutic effects. (7)F roma methodological perspective, in manyRCTsr andomisationi so nlyaf ormal criterion, and the intended control over confounding variables is probablynot achieved. In order toc ontrolf or differences between subjectsb y randomisation, as ufficientnumber of subjectsi sn ecessary(Hsu1989). In manyRCTsthe sample sizei sn otlargee nough toa chievee quivalentgroups byrandomisation( Hsu1989; Leichsenring &R abung 2006) . Fore xample, in the meta-analysisb yGloaguen, Cottraux,C ucherat,a nd Blackburn (1998) of the efficacyof cognitivetherapyin depression, only3 8% of the groupsh ad a sample sizeo fa tleast2 0patientsa nd only13%o fs amples had as izeo fa t least40patientsp er group, thusf ulfilling the criteria fora ne ffective randomisationa sf ormulated byHsu (1989) . Furthermore,p atientsf requently drop out from controlg roups,a dditionallyrestrictingthe comparability and representativenessofthe controlgroups tothe treatmentgroupeven in RCTs.
Effectiveness Studies
ContrarytoR CTs, effectivenessstudies arecarried out under the conditions of clinical practice. Theyareh ighlyrepresentativef or clinical practice ( Shadish, Matt,N avarro, &P hillips2000): patientswithc omplex(i.e. highlycomorbid) disorders (Guthrie 2000) , as theyusuallyoccurinclinical practice, aretreated. Therapistsa pplyexactlyt hosem ethods of psychotherapyt hatt heyare accustomed toa nd experienced in.P atientsa re referred tothe respective treatmentsi nthe standardwayof clinical practice, including their own preferencesand decisions regarding as pecific kind of therapyor foraspecific psychotherapist.T he durationo fthe treatmentis determined byt heirc linical requirements ( Seligman 1995) . Thus, effectiveness studies providee vidence of the resultso fatreatmentu nder the conditions of clinical practice. Forthis reason, Barkham etal. (2001) and Lucock etal (2003) usedthe term practicebased evidence tocharacterized atafromthe effectiveness research approach as contrasted tothe evidence-based treatmentapproach( efficacydata). Thesea uthors haved escribed as ystematic approachtog eneratep racticebased evidencef or routinetherapyservices.T he National Instituteo fM ental Healthi nthe USA( NIMH)h as specificallycalled form oree ffectiveness research (Krupnick etal.1 996) . TheU .K.D epartmentof Health( 1999) stressedthe need fore valuating psychotherapyservices in routine service conditions and the need tocompare outcome datafromroutineclinicalpractice withthoseobtained from RCTs(U.K. Departmentof Health, 1996) .
Limitations of EffectivenessStudies
According tothe considerations made above, the strengtho fe ffectiveness studies is their clinicalr epresentativenessa stheyarec arriedo ut under conditions of routinep ractice. As ac onsequence, however,e ffectiveness studies cannotcontrol forf actors affectingthe outcome tothe same extentas RCTs (internal validity). Thus, the main argumentagainsteffectivenessstudies ford emonstrating whether atreatmentw orksr efers top ossiblethreatsto internal validity,i .e., tothe reduceda bility toc ontrolf actorsi nfluencing the outcome independentof therapy.T hisi sl ikelyt ob ethe reason why effectivenesss tudies are notaccepted, fore xample, byt he American PsychologicalAssociationasamethodfor demonstratingthatatherapyworks. However,there is evidencethateffectiveness studies do notseem to overestimatee ffectsizes compared toR CTs. This evidence refers notonlyt o psychotherapy(Shadishe tal.2000), but alsotothe broader fieldo fE BM (Benson &H artz 2000; C oncato, Shah,&Horwitz 2000) . Forthe fieldo fE BM, Benson andH artz (2000)a nd Concato, Shah, and Horwitz (2000) c ompared the effectso fthe same treatmentappliedtoaspecific conditionf ound in effectivenesss tudies ("observational studies") withthoseo fR CTs. Theydid notfind systematic differences. Theyconclude thatt herei sl ittle evidence that effectsizes of well-designed effectivenesss tudies arel arger than or qualitativelydifferentfrom those found in RCTs.Shadishetal. (2000)r ated the clinical representativenesso fs elected psychotherapyoutcome studies. Non randomiseds tudies were rated as significantlymore clinicallyrepresentative. However,the authors didn otfind ac orrelationb etween clinical representativenessa nd effectsize. Thus, itcanb ec oncluded thatnonrandomiseds tudies did notoverestimatee ffectsizes compared tothose obtained in RCTs.
2 After all,thesef indings parallelthoser eported byBenson andH artz (200)and Concatoetal (2000) .
PhilosophyofScience andanA lternativePerspective
Taking more recentdevelopmentsi nthe philosophyof sciencei ntoa ccount,i t has recentlybeena rgued thatEBMa nd ESTa re implicitlybasedo na n outdated conceptiono fthe logical structure of scientific theories (Leichsenring 2004) , thatbeing the statementv iewas the standardc onception of scientific theories ( Hempel 1970) . Thes tatementv iewassumesuniversal validity or applicationo fatheory.R egardingR CTsa sthe "golds tandard" for psychotherapyoutcome researchi si mplicitlybasedo nthe statementv iew.I f, and onlyif,atherapyhas been proven toworkinacontrolledresearch setting (laboratory)c an itt henb ea pplied toc linicalp ractice( the field),b ased on the assumptionthatitworksequallyw ellinthe field.
Thes tatementv iewof scientific theories canb ec ontrasted withthe structuralistconception of scientific theories ( Sneed 1971; Stegmüller1 979; Westmeyer 1982,1 989) .I nthe structuralistconceptiono fs cientific theories the domain of intended applications is regarded as an integral componentof a theoryand the hypotheses derived from it.A ccording tothisc onception a theoryconsistso fatheory-coreKandasetIo fi ntended applicationso fK : "The inclusion of this latter setIi ntothe definition of atheory-elementis characteristic of the structuralistapproach. Itis af undamental tenetof structuralism,thatatheoryis notu niversallyapplicable, but onlyt oacertain set,r ange, or domain of intended applications" ( Westmeyer 1989, p. 4) .I n order toa pplyatheory,i tis necessaryt oe xtend the theory-core. This is achieved bystatingh ypotheses and specialc onditions thatare valid onlyfor the intended applications.T herefore, from as tructuralistv iewpoint,therea re no context-freeh ypotheses; hypothesesa lwaysr efer tos pecific contextso r intended applications.I nR CTs, hypotheses about the efficacyof treatments under controlledexperimental (idealized) conditions aretested; the selectionof patients, therapists, treatments, and outcome measures takes place within a research project.T hus, in RCTs,l aboratory-based hypotheses and modifications of real-life therapies are tested. For the latter, the term "laboratoryt herapies"h as been proposed (Leichsenring 2004) .I n effectivenesss tudies hypothesesr eferring tothe conditions of clinical practice aretested (field hypotheses and" fieldtherapies").T hus, itdepends on the intended applications whether an efficacyor effectivenesss tudies is tob e carriedout.I fthe hypothesis under studyrefers tolaboratorycontexts, an RCT is required;i fthe hypothesis refers ton atural conditions,a ne ffectiveness studyis required.
Thus, from astructuralistviewpoint,controlledand effectiveness studies do not fundamentallydifferi np rinciple concerning their externalvalidity,thatis the degree towhich the patients, therapists, treatments, settings and outcome measuresa re representativef or the conditions specified in the hypothesis under study,i no therwords,f or the domaino fi ntended applications. Furthermore, there is no differenceb etween RCTsa nd effectivenesss tudies concerningtheir internalvalidity.E xtensions of the theory-core and intended applications in referencetol aboratoryconditions willl ead tos impler hypotheses and tomore rigorousspecial conditions.I nc ontrast,e xtensions of the theory-corea nd intended applications in referencetof ield conditions will havetoc ompensatefor reducede xperimental controlwithm ore liberal special conditions and correspondinglyextended hypotheses.Adifferencei ni nternal validity does notarise( foramore detailedd iscussions ee Westmeyer 1982) . Thus, from as tructuralistv iew,R CTsa nd effectiveness studies do not fundamentallydiffer concerning theirinternal or external validity,a nd RCTs do notnecessarilyprovidehigher-level evidencethan effectivenessstudies.
As efficacystudies providee videncef roma ni ntended applicationd ifferent from clinical practice, empiricale videncef rom RCTs cannotbe directly transferred tothe conditions of the field. If am ethod of psychotherapyhas been showntoworkunder laboratoryconditions (efficacy), thisd oes not necessarilyimplyt hatitequallyw orks under naturalconditions (effectiveness). Therei sn oj ustificationf or an inductiveg eneralizationf rome xperimental to non-experimental conditions of everydayreality (Bredenkamp1 980; Leichsenring 1985) .T he effectiveness of atreatmentu nder natural conditions canb ed emonstrated onlybyeffectivenesss tudies.F or thisr eason, the RCTs listed bythe APA (Chambless&Hollon 1998;Chambless &Ollendick2001) as empiricals upportfors pecific psychotherapeutic methods showonlyt hatt hese methods work under experimental (laboratory)c onditions.T hatt heyw ork equallyw elli nthe field hasn oty etbeen demonstrated. One of the main reasons forthe gapb etween experimental (laboratory)c onditions and clinical practicei sthatpsychotherapyis notad rugthatw orks equallyu nder different conditions.D ifficult-to-quantifyfactorsi nthe therapist-patientmatch may influenceo utcome.T hus, itis questionablewhether the methodologyof pharmacological research is adequatef or psychotherapyresearcho fm ental disorders,a tleastw henthe effectivenesso fatreatmentin clinical practicei s tobestudied. After all, RCTs serveonlyalimited function(Roth&Parry1997).
Levels of Evidence:anA lternativePerspective
Taking intoaccountt he differentintended applications associated withe fficacy and effectivenesss tudies,the schemes of levels of evidencewhich regard RCTs as the gold standard( Canadian Task Forceo nthe Periodic Health Examination1 979; Chambless&Ollendick 2001; Cook etal.1 995; Guyatt et al.1 995; Nathan &G orman, 2002) r efer totreatmentsunder laboratory conditions (efficacystudies). Thus, theycannotbe applied tothe questiono f whether atherapyworks under conditions of routinepractice. For effectiveness studies,which bydefinitioncannotu se randomisation, levelso fe videncem ust be defined bycriteria differentfrom those of efficacystudies.
3 For this reason, ithasb een proposed thatt he criteria and levels of evidence forR CTs should be separated from thosefor effectivenessstudies (Leichsenring2004).
Levels of Evidence of Effectiveness Studies
For the empirical supportof treatmentsa pplied in field settings,a nother parallels chemei sn ecessaryt od escribe the levels of evidence in effectivenesss tudies.S uch as chemeh as totakei ntoa ccountt he quality of effectivenesss tudies.T he criteria defining the quality of effectivenesss tudies cannotbe identical tothoseo fR CTs,a lthough theymayoverlap. High-level evidencef or the effectiveness of atreatmentis provided byhigh-level effectivenesss tudies.B yw hatcriteria canh igh-level effectiveness studies be defined? Shadish etal. (2002) h aved escribed experimental and quasi-experimental designs forg eneralized causalinference.A ccordingtoShadishetal. ( 2002), a causali nference from aq uasi-experimental studymustmeett hree basic requirements: cause mustprecedee ffect,c ause mustco-varyw ithe ffect,a nd alternativee xplanations of the effectmustbe implausible. As quasiexperimental studies do notu se random assignment,theyhavetouse other principles tos howt hatalternativee xplanations of the effectare implausible. Theseprinciples include:
1.
Theidentification and studyof plausiblethreatstointernal validity, 2.T he use of additional design elements( e.g.,o bservationa tmore pretesttimepoints, additionalcomparison groups)orofstatistical controls,and 3.C oherentpatternm atching,thatis,p redictiono fc omplexpatterns of results(e.g.,non-equivalentdependentvariablesorinteractions). depression (Erwin etal.2002) , and expectations of therapy (Chambless, Tran, &G lass1 997) . When included in as tudydesign, these variablesc an be examined withr egard totheire ffectso ntherapyoutcome.T he more thatt he predicted differentiale ffectso ccur, the less probablei tis thatt he changes observed canbeattributed tofactorsother than the method of therapyapplied. Furthermore, accordingtoarecentproposal 'change norms'c an be useda s additional design elements ( Leichsenring&Rabung 2006) . Furthermore processr esearchc an contributetoamore stringentconclusion thatan observed effectis associated withthe interventions applied. In an open study of psychodynamic therapyford epression, Hilsenrothe tal. ( 2003)s howed that the observed effectswerea ssociated withthe definingf eatures of psychodynamic therapybut notw iththe defining features of cognitivebehaviouraltherapy.
Taking theser efined methodological issues intoa ccountap roposal has been made tog rade the levelso fe videnceo fe ffectiveness studies (Leichsenring 2004) . According tothisp roposal,ahigh-level effectivenesss tudyis a prospectiveq uasi-experimental studyof high clinical representativeness, characterized bynon-random comparison groups,the matchingorstratifyingof groups,clear descriptions of treatments, patientsand their selection, the use of reliable and valid diagnostic proceduresa nd outcome measures, the use of additional designe lements, coherentpatternm atching, reporting of drop outs, pre-and post-assessments, follow-ups tudies,a nd the reportingo fr elevant statistical data. Clinical representativenessi sa chieved byt he selectiono f patients, therapists, andtreatmentsthatare typical forc linical practice ( Wells 1999; Shadish etal.2000) . Plausiblethreatstoi nternal validity arec ontrolled forb yt he use of additional designe lements( e.g.,o bservationa tmore pretest timep oints, additionalc omparison groups), statistical controls,o rc oherent pattern matching, thatis,p redictiono fc omplexpatterns of results( e.g.,n onequivalentdependentv ariables or interactions). According tothisd efinition, the golds tandardo fe ffectivenesss tudies (effectivenesss tudies) is a prospectiveq uasi-experimental studyof high clinical representativenessthat fulfills allo ra tleastmostof the aforementioned criteria.L ower-level effectivenesss tudies differ from high-level studies in one or more of these aspects ( Leichsenring 2004) . In ordertoj udge the effectivenessofamethod of therapy(inaspecific disorder)i nc linical practice, the existings tudies haveto be rated withr egard totheirlevelso fevidenceaccording tocriteria thatremain tob ed efined. Furthermore, definitions mustbe given thatares imilar tothose of the APAg uidelines concerning the number of studies regarded as necessary.F or atreatmentt ob ej udged as "effective" in clinical practice, at leastt woi ndependentlevel Is tudiesm aybe regarded as necessary.T ob e judged as "probablyeffective,"o ne level Is tudymaybe regarded as necessary.
ComplementaryRelationshipofEfficacy andEffectiveness Studies
As discusseda bove, efficacyande ffectivenesss tudies addressd ifferent research questions:RCTs examinethe efficacyof atreatmentundercontrolled experimental conditions,whereas effectivenesss tudies address the effectivenessunder clinical practicec onditions.A saconsequence, the relationshipb etween RCTs and effectiveness studies is notcompetitive; rather,i tis complementary.F romthisp erspective, ad istinction between empiricallysupported therapies (EST)a nd RCTm ethodologyis required (Leichsenring2004; Westen, Novotny,&Thompson-Brenner 2004) .
Discussion
Thep resentarticle addressesthe discussiono fe fficacyv s. effectiveness in psychotherapyoutcome research.C onsiderations from the viewof the philosophyof scienceh aves hownthatmethodological questions cannotbe answered in isolationf romc ontent,i .e.f romthe questiono fr esearch. Buchkremer and Klingberg (2001) proposed thatt he testingo fp sychotherapy should be conceptualised as analogoustothe testingo fp harmacological treatments. As noted above, the essential argumentagainstsuch am odel is thatpsychotherapyis notad rugthatw orks equallyu nderd ifferentconditions, i.e. in the laboratoryof ar esearch projectandi nthe fieldo fc linical practice. Ther esultso fs ocialp sychologyexperimentsa lone (e.g. Thep resentlyavailablep roposalsm adetod efinee vidence-based psychotherapeutic treatmentsr efer tothe treatmentof as pecific mental disorder (e.g.p anic disorder). However, resultso fe pidemiological studies haves hownthatmostpatientsd on otsuffer from an isolated mental disorder (Kessler etal.1 994; K essler,C hiu,D emler, &W alters 2005) . Rates of comorbidity aretypicallyhigh, and mostpatientsare multimorbid. However, as mentioned above, the treatmentmanualsp resentlyavailable describe the treatmentof as pecific isolated mental disorder.T heydo notanswer the questiono fh owt otreat,f or example, am ajor depressived isorder associated withapost-traumatic stress disorder and an arcissistic personality disorder.I t is widelyu nknownh oweffectivethe empiricallysupported treatmentsf or depressived isorders,a sl isted fore xampleb yChamblessa nd Hollon (1998) or Nathan and Gorman( 2002) , are in the treatmentof highlycomorbid patients. Furthermore, the emphasis on highlystructuredp sychotherapeutic methods tailoredtothe treatmentof as pecific mental disorder corresponds to ac onceptualisation of psychotherapy-likec ognitive-behavioural therapyrather thantoo ther formso fp sychotherapy,e .g.p sychodynamic therapy.T hus, itis no surprisethatt he EST approachwas initiated byproponentso fC BT Hollon1998, Chamblessand Ollendick2001) .Furthermore, a highlystructuredc onceptualisationo fp sychotherapyseemstoc orrespond to specific personality traitsthatw eref ound in CBTtherapistsr ather than in psychodynamic therapists ( Topolinski &Hertel, 2007) .
Certainly,the differentiationo fr andomisedc ontrolled (laboratory)s tudies and effectivenesss tudies,onwhichthisa rticle hasf ocused, is notan ewidea (e.g. Seligman 1995; Wells1 999 From the differentiationi ntol aboratoryand fieldtypes of evidence, an ew research agenda fore ffectiveness studies canb ed erived which is analogous tothatof efficacystudies (Leichsenring2004). This research addressesh ow effectivep sychotherapeutic methods in specific,though comorbid disorders (e.g.d epression, anxiety disorders,s omatoformd isorders,h ighlycomorbid disorders)a re in clinical practice. Therea re atleastt wod ifferentstrategies:I n the first,the effectiveness of therapies thatare alreadyappliedi nthe fieldi s evaluated (e.g.S eligman 1995);i nthe second, psychotherapeutic methods thathad been tested in RCTs are applied and, if necessary,m odified in clinical practice( e.g. Hahlweg, Fiegenbaum, Frank,S chroeder, &von Witzleben 2001) . Atpresent,o nlyaf ewstudies of thistype fors pecific disorders exist, e.g. forp anic disorders (Wade, Treat,&Stuart1998; Hahlweg etal.2001) , depression (Peterson&Halstead 1998;P ersons,B ostrom&Bertagnolli 1999; Organista, Munoz&G onzales 1994),b ulimian ervosa( Tuschen-Caffier,P ook &F rank 2001) or fore xternalisingd isorders in children and adolescents (Tynan, Schumann &L ampert1999) . Initialr esultsshow,thatin routineclinical practicep atientsd on otprofitfrom specific methodso ftherapyt othe same extentas was reported from RCTs,thatt herapies arec arried out foralonger time, or thatadditional elementso ftherapyare added,e .g., psychopharmacological therapy(Chambles &Ollendick2001, p. 711). In other words,the laboratoryformso ftherapyaren otpurelyappliedi nc linical practice: modified versions areused. Theser esultss howt hatdataf rom experimental conditions cannotdirectlybe transferred toclinicalpractice.
Thep resentarticle explicitlycalls foradefinitiono fthe criteria thatdetermine the level of quality of an effectivenesss tudy.B ydefinition, effectiveness studies cannotuse randomisationwiththe exceptionofwaiting-listcomparison conditions.T heyhavetoa pplyothers trategies toe nsure internal validity. According tothe extenttowhich internal,external,and otheraspectsofvalidity aree nsured, differenteffectivenesss tudies maydifferc oncerningtheirl evels of evidence.W hereas external validity of effectivenesss tudies concerning the treated patientsc an be ensuredr elativelyeasily(e.g.b ycomparison with epidemiological data), thisi sm ored ifficultw ithr egardtotherapists. For this purpose, datao fr elevantfeatures of therapistsa re required (Wells 1999) . Internal validity of bothe ffectivenesss tudies and RCTs canb er educedb y several factors, one beings mall sample size. Withi nsufficientsample size, small differences between( nonrandomised) groups in effectiveness studies aren otdetected withsufficientpower (Wells 1999) . In RCTs itis questionable whether randomisationl eads toe quivalentgroups if the sample sizei s insufficient(Hsu1989). Dropoutsc an impairthe internal validity in bothtypes of studies. Here, intent-to-treatanalysesa re required (Wells 1999) . Moreover, there is empiricale videncethatrandomisationi so ften incorrectlycarriedo ut, and thatnon-random manipulations of comparison groups are made (Schulz, Chalmers, Grimes &A ltman1 994).T he resultsp resented byShadish atal. (2000)are relevantw ithr egard tothe appropriatenesso fe ffectivenessstudies as methods fortestingifatreatmentw orks. Shadish atal. (2000)did notfind a significantcorrelationb etween the degree of clinical representativeness( e.g., RCTs vs. effectivenesss tudies) andthe sizeo fthe effectsr eported in studies of psychotherapy.T hus, the conclusion canb ed rawnthat(high-level) effectivenesss tudies do notsystematicallyoverestimatethe effectso f psychotherapy.
Theproposal forlevels of evidencemade in thisarticle canbeusedinboththe judgmentof existinge ffectivenesss tudies and planning of newstudies.T his proposalisintended tostimulatescientific discussion.
Finally,itshould be noted thatt he differentiationbetween pure efficacystudies and pure effectivenesss tudies is somewhatarbitrary.T he distinctionb etween these twotypes of studydesigns canb em oreb lurred than described in this paper so far (Guthrie. 2000) . In RCTs, forexample, elementso fr outineclinical practicec an be implemented (e.g.treatmentsa stheyareusuallyapplied in clinical practiceo rp atientsa stheyu suallyt reated in clinical practice).A lsoi n effectivenessstudies elementsofRCTscan be used, forexamplepatientswith specific mental disordersc an be included. However,thesep atientsusually shownotonlyone, but multiple mental disorders.I fr andomisationi susedina studycarriedo ut under the conditions of clinical practice, the representativenessf or clinical practicei sr educed, because patientsa re not referred tothe treatmentsb yt he usual wayso fc linical practicei ncluding their ownp references foraspecific type of treatmentor fora ni ndividual therapistthe one exceptionwas described above. Thus, ac ontinuumm aybe more appropriatethanadichotomousd istinctionb etween experimental and effectivenesss tudies with" pure" RCTs markingthe onep ole and" pure" 
